GSM signal measures "ferritin, ferroportin, transferrin, divalent metal transporter 1, several gene markers of myelinating oligodendrocytes" ( Cohen Z et al 2024). Claassen called the change "atrophy" what he saw in his BioMuse population to happen in 6 and 12 months. But was it demyelination? He also knows what the ATH434 effect looks like. Is it "remyelination" that should correlate to function? I cannot imagine ferritin, ferroportin, etc relate so well to the volume than myelin.
JULY IS HERE !!!, page-60
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.4¢ |
Change
0.001(33.3%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.4¢ | $1.2K | 300K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 23270862 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 133219922 | 34 |
View Market Depth
| Last trade - 09.59am 11/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |